Pharmacogenetics of Response to Sitagliptin (PRS)
Part of paid clinical trials in Lancaster, Pennsylvania.
- Sponsor
- University of Maryland, Baltimore
- Study ID
- NCT06813014
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Oral Glucose Tolerance Test — PROCEDUREThree hour glucose tolerance test
Study Details
This is a research study to find out how different people respond to a medication called sitagliptin. Sitagliptin is an FDA approved medication that is used to treat diabetes. We are asking for healthy, non-diabetic volunteers to participate in this 7-week study. If you agree to participate, you will take part in 2 clinic visits that are 4-6 weeks apart. At the clinic visits you will have an oral glucose tolerance test (OGTT) and other blood tests to see how your body processes glucose (sugar). An OGTT is a test in which your drink glucose and then blood samples are taken afterward at specific time points to measure glucose and insulin in your blood. Each clinic visit will last about 5 hours.
Key Dates
- Start date
- Dec 31, 2026
- Status verified
- Feb 2026
- Primary completion
- Nov 30, 2031
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: SitagliptinSitagliptin 100 mg given 2 hours prior to the oral glucose tolerance test
- Placebo Comparator: PlaceboPlacebo given 2 hours prior to the oral glucose tolerance test
Primary Outcome Measure
Sitagliptin-induced enhancement of early insulin secretion [ Time Frame: 6 weeks ]
Central Contacts
- Amber L Beitelshees14107060118
- Kamah Woelfel
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Maryland Amish Research Clinic | Lancaster | Pennsylvania | 17602 | - |
Find similar trials in Lancaster, PA
Related Studies
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose IntolerancePHASE2 · Recruiting · University of Pennsylvania · Aurora, Colorado
- Diabetes Clinical Decision SupportRecruiting · Milton S. Hershey Medical Center · Hershey, Pennsylvania
- The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectEnrolling By Invitation · Marinella Temprosa · Phoenix, Arizona
- DFC 004 Biomarkers for Active Diabetic Foot UlcersRecruiting · University of Michigan · Tucson, Arizona